Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar;76 Suppl 1(Suppl 1):S83-S85.
doi: 10.1016/j.ihj.2023.12.012. Epub 2023 Dec 29.

Dyslipidaemia in endocrine disorders

Affiliations
Review

Dyslipidaemia in endocrine disorders

Kalyani Sridharan et al. Indian Heart J. 2024 Mar.

Abstract

Lipid disorders are common in several endocrine conditions. Diabetes mellitus, hypothyroidism and Cushing's syndrome are the common endocrine disorders with dyslipidemia. Dyslipidemia has a significant impact on endocrine and metabolic health and the risk of atherosclerotic cardiovascular disease. In most cases of dyslipidemia, the suspicion of endocrine diseases must be based on clinical symptoms and signs. Optimal management of the dyslipidemia requires treatment of the underlying endocrine condition. Lipid lowering therapy is a useful adjunct or a requirement in many cases. The Indian guidelines provide a pragmatic and practical approach to the management of lipid disorders in endocrine disease, as well as endocrine vigilance with lipid therapy.

Keywords: Endocrine disorders; Lipid disorders; dyslipidemia.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

    1. Kalra S., Priya G. Lipocrinology - the relationship between lipids and endocrine function. Drugs Context. 2018;7 - PMC - PubMed
    1. Feingold K., Brinton E.A., Grunfeld C. In: Endotext [Internet] De Groot L.J., Choruses G., Dungan K., Feingold K.R., Grossman A., Hershman J.M., editors. MDText.com, Inc.; South Dartmouth (MA): 2000. The effect of endocrine disorders on lipids and lipoproteins.
    1. Ł Bułdak, Marek B., Kajdaniuk D., et al. Endocrine diseases as causes of secondary hyperlipidemia. Endokrynol Pol. 2019;70(6):511–519. - PubMed
    1. Newman C.B., Blaha M.J., Boord J.B., et al. Lipid management in patients with endocrine disorders: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2020;105(12):dgaa674. - PubMed
    1. Kota S.K., Kota S.K., Jammula S., et al. Hypertriglyceridemia-induced recurrent acute pancreatitis: a case-based review. Indian J Endocrinol Metab. 2012;16(1):141–143. - PMC - PubMed